WAP
MIST icon

Wealthcare Advisory Partners’s Milestone Pharmaceuticals MIST Stock Holding History

Wealthcare Advisory Partners’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-352
Closed -$2K – 1325
2021
Q1 		$2K Buy
+352
New +$2.58K ﹤0.01% 1885
2020
Q2 		– Sell
-52
Closed – – 952
2020
Q1 		$0 Hold
52
– – ﹤0.01% 1551
2019
Q4 		$1K Hold
52
– – ﹤0.01% 1333
2019
Q3 		$1K Hold
52
– – ﹤0.01% 1293
2019
Q2 		$1K Buy
+52
New +$1.07K ﹤0.01% 1260

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Wealthcare Advisory Partners's MIST Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Milestone Pharmaceuticals (MIST) in Q2 2021, closing a stake of 352 shares — an estimated $2K sold.

Wealthcare Advisory Partners first reported a position in MIST in Q2 2019 and held it in 5 quarters. The position peaked at $2K in Q1 2021. 28 funds tracked by Wall St. Rank hold MIST as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Milestone Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 352 Milestone Pharmaceuticals shares in Q2 2021, an estimated $2K.
  • Wealthcare Advisory Partners first reported a position in Milestone Pharmaceuticals in Q2 2019 and held it in 5 quarters.
  • Wealthcare Advisory Partners's Milestone Pharmaceuticals position peaked at $2K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.